Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Aug 15;8(3):145.
doi: 10.3390/reports8030145.

Personalized Management of Hydroxyquinoline Hypersensitivity in Pessary Care: A Case-Based Approach to Tailored Treatment

Affiliations
Case Reports

Personalized Management of Hydroxyquinoline Hypersensitivity in Pessary Care: A Case-Based Approach to Tailored Treatment

Nadege Assassi et al. Reports (MDPI). .

Abstract

Background and Clinical Significance: Many women use pessaries to manage their symptoms of pelvic organ prolapse. Hydroxyquinoline is the active ingredient in gels and ointments that are often used to lubricate a pessary prior to vaginal insertion and to provide antimicrobial effects while the pessary is in situ. Case Presentation: A 74-year-old woman with multiple medication allergies develops vulvovaginal erythema and pruritus after increasing vaginal Trimo-San application frequency for pessary care and maintenance. These symptoms are deemed to be consistent with an allergic reaction to hydroxyquinoline, the active ingredient in Trimo-San. Conclusions: This report highlights the importance of personalized treatment in pessary management. It also demonstrates how personalized medicine can optimize outcomes and improve treatment adherence among individuals with complex medical histories.

Keywords: allergy; case report; dermatitis; hydroxyquinoline; pelvic organ prolapse; pessary.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Vaginal epithelium at initial office evaluation.
Figure 2
Figure 2
Vaginal epithelium after Trimo-San discontinuation.
Figure 3
Figure 3
Case Timeline.

References

    1. American College of Obstetricians and Gynecologists. American Urogynecologic Society Pelvic organ prolapse: ACOG practice bulletin, number 214. Female Pelvic Med. Reconstr. Surg. 2019;25:397–408. doi: 10.1097/SPV.0000000000000794. - DOI - PubMed
    1. Progetto Menopausa Italia Study Group Risk factors for genital prolapse in non-hysterectomized women around menopause. Results from a large cross-sectional study in menopausal clinics in Italy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2000;93:135–140. doi: 10.1016/S0301-2115(00)00285-2. - DOI - PubMed
    1. Vergeldt T.F., Weemhoff M., IntHout J., Kluivers K.B. Risk factors for pelvic organ prolapse and its recurrence: A systematic review. Int. Urogynecol. J. 2015;26:1559–1573. doi: 10.1007/s00192-015-2695-8. - DOI - PMC - PubMed
    1. Lethaby A., Ayeleke R.O., Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst. Rev. 2016;2016:CD001500. doi: 10.1002/14651858.CD001500.pub3. - DOI - PMC - PubMed
    1. Propst K., Mellen C., O’Sullivan D.M., Tulikangas P.K. Timing of Office-Based Pessary Care. Obstet. Gynecol. 2020;135:100–105. doi: 10.1097/AOG.0000000000003580. - DOI - PubMed

Publication types

LinkOut - more resources